Eli Lilly’s Alzheimer’s drug wins FDA approval
An Eli Lilly & Co. Alzheimer’s drug won Food and Drug Administration approval Tuesday, capping the medication’s bumpy ride through the U.S. regulatory process and adding a second new treatment option for patients in earlier stages of the disease.
Article Attribution | Read More at Article Source
[mwai_chat context=”Let’s have a discussion about this article:nnAn Eli Lilly & Co. Alzheimer’s drug won Food and Drug Administration approval Tuesday, capping the m
Read more »